Summary#
The bill adds a new, specific legal definition of “plant biostimulant” to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). It also narrows the law’s definition of “plant regulator” so certain biostimulants are not treated as plant regulators. The bill requires the EPA to update regulations quickly and directs the USDA to study how biostimulants can improve soil health and related outcomes.
- Main change: Creates a statutory definition of “plant biostimulant” (substance, microorganism, or mix that supports a plant’s natural processes, independent of its nutrient content, and improves nutrient availability/use, tolerance to non-living stress, and growth/quality/yield).
- Exclusion: Changes the “plant regulator” definition so that biostimulants of biological origin, or synthetically made but structurally and functionally identical to biological substances, are not plant regulators.
- New definitions: Adds definitions for “nutritional chemical” (substances that interact with plant nutrients and can include some biostimulants) and “vitamin hormone product.”
- Regulatory timing: EPA must revise relevant regulations within 120 days after the bill becomes law.
- Study requirement: USDA must study which biostimulants and practices best increase soil organic matter, reduce volatilization, limit runoff/leaching, restore soil bioactivity, aid carbon sequestration, and support performance-based sustainability approaches, and report publicly within two years after funds are provided.
What it means for you#
- Farmers and growers
- Producers could see more products labeled and sold as “plant biostimulants” rather than as plant regulators or pesticides, depending on product origin and ingredients.
- The USDA study may produce guidance on which biostimulants and practices help soil health, nutrient use, and climate-related outcomes.
- Manufacturers and sellers of agricultural inputs
- Companies that make microbial or biologically derived products may be able to market them as biostimulants and avoid being regulated as plant regulators under FIFRA if they meet the new definitions.
- Producers of synthetic compounds that closely match biological substances could also qualify for the exclusion if they are “structurally similar and functionally identical.”
- Some products may need relabeling or regulatory reclassification once EPA updates regulations.
- Environmental and soil scientists / extension services
- The USDA study may generate data and recommended practices for improving soil health and reducing nutrient losses.
- EPA and USDA
- EPA must revise regulations within 120 days, which will change how agencies classify and review some products.
- USDA must run a multi-topic soil health study and publish a report within two years after funds are made available.
- Home gardeners and landscapers
- Some garden products could be marketed as biostimulants; practical effects depend on labeling and availability.
What is unclear:
- The bill does not set funding levels for the USDA study.
- The bill does not list new labeling, testing, or reporting requirements for products labeled as biostimulants.
(Rhizosphere = the soil immediately surrounding plant roots.)
Expenses#
No publicly available information.
- EPA will have administrative costs to revise regulations within 120 days; the bill does not specify funding or estimates.
- USDA will incur costs to carry out the soil health study and prepare the report; the bill says the report is due within two years after funds are first made available, but it does not authorize or specify funding amounts.
- Manufacturers may face private costs to relabel or reclassify products, or to provide data to qualify for the new definitions; those costs are not estimated in the bill.
Proponents' View#
- The bill appears intended to create a clear, consistent legal category for plant biostimulants so that biologically based products are not treated the same as plant regulators under FIFRA.
- Supporters may argue this could reduce regulatory uncertainty for producers and speed adoption of biologically based products.
- The USDA study aims to identify which biostimulants and practices help soil organic matter, reduce nutrient losses, and support carbon sequestration and other climate-related benefits.
- Creating definitions for “nutritional chemical” and “vitamin hormone product” may clarify overlaps between product categories.
Opponents' View#
- One concern is that excluding certain biostimulants from the “plant regulator” category could reduce regulatory oversight of products that affect plant growth, with unclear consequences for safety, efficacy, and environmental impact.
- The bill does not set standards for proving a product meets the biostimulant definition (for example, how to show a synthetic compound is “structurally similar and functionally identical”), which may leave ambiguity for regulators and industry.
- The 120‑day deadline for EPA rule updates is short and may be difficult to meet for detailed guidance.
- The USDA study depends on funds “first made available”; with no funding specified, it is uncertain when the study will start or how thorough it will be.